Overview

The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris

Status:
Unknown status

Trial end date:
2017-08-01

Target enrollment:

Participant gender:

Summary

This is a randomized, double-blind, placebo-controlled, adaptive clinical trial, which will assess the effect of DanshenDuofensuanyan[Danshen (a kind of Chinese herbal drug) extract] treatment on Lipoprotein associated phospholipase A2 level in patients with stable angina pectoris.

Phase:

Phase 4

Details

Lead Sponsor:

Taizhou Fourth People's Hospital

Collaborator:

Shanghai 10th People's Hospital